Literature DB >> 8373796

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

G Haran1, R Cohen, L K Bar, Y Barenholz.   

Abstract

Gradients of ammonium sulfate in liposomes [(NH4)2SO4]lip. > [(NH4)2SO4]med. were used to obtain 'active' loading of amphipathic weak bases into the aqueous compartment of liposomes. The loading is a result of the base exchange with the ammonium ions. This approach was applied to encapsulate anthracyclines and acridine orange inside the liposomes at very high efficiency (> 90%). Doxorubicin was accumulated in the aqueous phase of the liposomes where it reached a level as high as 100-fold the doxorubicin concentration in the remote loading medium. Most of the intraliposomal doxorubicin was present in an aggregated state. The active entrapment and loading stability were dependent on liposome lipid composition, lipid quality, medium composition and temperature, as well as on the pKa and hydrophobicity of the base. The ammonium sulfate gradient approach differs from most other chemical approaches used for remote loading of liposomes, since it neither requires preparation of the liposomes in acidic pH, nor to alkalinize the extraliposomal aqueous phase. The stability of the ammonium ion gradient is related to the low permeability of its counterion, the sulfate, which also stabilizes anthracycline accumulation for prolonged storage periods (> 6 months) due to the aggregation and gelation of anthracycline sulfate salt.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373796     DOI: 10.1016/0005-2736(93)90105-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  200 in total

1.  Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.

Authors:  S Bandak; A Ramu; Y Barenholz; A Gabizon
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.

Authors:  Azadeh Kheirolomoom; Lisa M Mahakian; Chun-Yen Lai; Heather A Lindfors; Jai Woong Seo; Eric E Paoli; Katherine D Watson; Eric M Haynam; Elizabeth S Ingham; Li Xing; R Holland Cheng; Alexander D Borowsky; Robert D Cardiff; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-12-06       Impact factor: 4.939

3.  Targeted nanogels: a versatile platform for drug delivery to tumors.

Authors:  Eric A Murphy; Bharat K Majeti; Rajesh Mukthavaram; Lisette M Acevedo; Leo A Barnes; David A Cheresh
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

4.  Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy.

Authors:  Sang-Min Lee; Richard W Ahn; Feng Chen; Angela J Fought; Thomas V O'Halloran; Vincent L Cryns; Sonbinh T Nguyen
Journal:  ACS Nano       Date:  2010-09-28       Impact factor: 15.881

5.  Bioresorbable Vesicles Formed through Spontaneous Self-Assembly of Amphiphilic Poly(ethylene oxide)-block-polycaprolactone.

Authors:  P Peter Ghoroghchian; Guizhi Li; Dalia H Levine; Kevin P Davis; Frank S Bates; Daniel A Hammer; Michael J Therien
Journal:  Macromolecules       Date:  2006-03-07       Impact factor: 5.985

6.  The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™.

Authors:  Nilesh Patankar; Malathi Anantha; Euan Ramsay; Dawn Waterhouse; Marcel Bally
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

7.  Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.

Authors:  Dandan Luo; Jumin Geng; Nasi Li; Kevin A Carter; Shuai Shao; G Ekin Atilla-Gokcumen; Jonathan F Lovell
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

8.  Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.

Authors:  Junhwa Shin; Pochi Shum; Jessica Grey; Shin-ichi Fujiwara; Guarov S Malhotra; Andres González-Bonet; Seok-Hee Hyun; Elaine Moase; Theresa M Allen; David H Thompson
Journal:  Mol Pharm       Date:  2012-10-03       Impact factor: 4.939

Review 9.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

10.  Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate.

Authors:  Jeremy A Boomer; Marquita M Qualls; H Dorota Inerowicz; Robert H Haynes; V Srilakshmi Patri; Jong-Mok Kim; David H Thompson
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.